SCD support study using mobile app
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a mobile app to help people with sickle cell disease manage their health. It's designed for those who have a compatible smartphone and internet access.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of sickle cell disease (any type) in your medical records.
- You own a mobile device that works with the app (like a smartphone or tablet).
- You have internet access (Wi-Fi or data plan).
- You do not plan to move away from the study area in the next year.
- You are not switching to adult care within the next 12 months (if you are a child).
- You can use the app and take part in the study (no severe thinking or memory problems).
- You speak English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses text messages to help adults with sickle cell disease learn about the latest medical guidelines and tools to manage their health. The goal is to see if this mobile approach improves how people follow their care plan.
This study tests a new way to screen babies for sickle cell disease at the point of care. It aims to make screening faster and easier for families and health workers.
This trial tests a way to help teens and young adults with sickle cell disease (SCD) and their caregivers actively take part in treatment decisions. It focuses on improving shared decision-making through interviews and a partner-centered approach.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
This study collects feedback through surveys, interviews, and focus groups from people affected by sickle cell disease. Your input helps the research team improve how genomic and gene-therapy information and needs are understood for patients and caregivers.
This trial tests whether a computer-based “attention control” training program can improve attention and daily functioning in children with sickle cell disease. To join, you must meet certain criteria and also pass an initial attention screening test during the study.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.